[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000601:surgery*; D001161:Arteriosclerosis / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011184:Postoperative Period; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D010919:Placebos; D013442:Sulfinpyrazone
Sulfinpyrazon (Anturan) versus Placebo nach operativer Rekonstruktion der Oberschenkeletage bei arterieller Verschlusskrankheit.